The MarketWatch News Department was not involved in the creation of this content. TUSCON, Ariz., March 09, 2026 (GLOBE NEWSWIRE) -- The mechanism of action of mRNA vaccines goes far beyond harnessing ...
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m(1) TP). The ...
The biotech company said the FDA won't review its flu vaccine, in the latest hit to mRNA development As COVID-19 vaccine sales dwindle, pressure on Moderna to grow its business has increased.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results